NYLIM
MED icon

New York Life Investment Management’s Medifast MED Stock Holding History

New York Life Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,344
Closed -$225K – 1447
2023
Q4 		$225K Sell
3,344
-90
-3% -$6.27K ﹤0.01% 1280
2023
Q3 		$257K Sell
3,434
-541
-14% -$48K ﹤0.01% 1233
2023
Q2 		$366K Sell
3,975
-1,201
-23% -$107K ﹤0.01% 1118
2023
Q1 		$537K Buy
+5,176
New +$574K 0.01% 643

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

New York Life Investment Management's MED Position: Q1 2024 in Review

New York Life Investment Management sold out of Medifast (MED) in Q1 2024, closing a stake of 3,344 shares — an estimated $225K sold.

New York Life Investment Management first reported a position in MED in Q1 2023 and held it in 4 quarters. The position peaked at $537K in Q1 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • New York Life Investment Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 3,344 Medifast shares in Q1 2024, an estimated $225K.
  • New York Life Investment Management first reported a position in Medifast in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Medifast position peaked at $537K in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.